PROFUSA, INC. Interest Expense Nonoperating
PROFUSA, INC. (PFSA) reported Interest Expense Nonoperating of $21.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-19
- PROFUSA, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $21.00K, a 98.24% decline year-over-year.
- PROFUSA, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $18.00K, a 98.41% decline year-over-year.
- PROFUSA, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $25.00K, a 98.06% decline year-over-year.
- PROFUSA, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $169.00K, a 84.25% decline year-over-year.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.00K 10-Q · filed 2026-08-19 | $39.00K 10-Q · filed 2026-08-19 | $64.00K derived: sum of 3 quarters · filed 2026-08-19 | $233.00K derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-15 | $43.00K derived: sum of 2 quarters · filed 2026-05-15 | $212.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.41M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $25.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $194.00K derived: sum of 2 quarters · filed 2026-05-01 | $1.39M derived: sum of 3 quarters · filed 2026-08-19 | $2.52M S-1/A · filed 2026-05-01 |
| 2025-09-30 | $169.00K 10-Q · filed 2025-11-19 | $1.36M derived: sum of 2 quarters · filed 2026-08-19 | $2.50M 10-Q · filed 2025-11-19 | $3.78M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $1.19M 10-Q · filed 2026-08-19 | $2.33M 10-Q · filed 2026-08-19 | $3.61M derived: sum of 3 quarters · filed 2026-08-19 | $4.69M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | $1.14M 10-Q · filed 2026-05-15 | $2.42M derived: sum of 2 quarters · filed 2026-05-15 | $3.49M derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $1.29M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $2.36M derived: sum of 2 quarters · filed 2026-05-01 | $4.42M S-1/A · filed 2026-05-01 | |
| 2024-09-30 | $1.07M 10-Q · filed 2025-11-19 | $3.14M 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |